이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Meta Health 과거 수익 실적

과거 기준 확인 0/6

Meta Health의 수입은 연평균 -20%의 비율로 감소해 온 반면, Machinery 산업은 수입이 연평균 12%의 비율로 증가했습니다. 매출은 연평균 14.6%의 비율로 감소해 왔습니다.

주요 정보

-28.3%

수익 성장률

-16.9%

EPS 성장률

Machinery 산업 성장	12.0%
매출 성장률	-32.3%
자기자본 수익률	n/a
순이익	-132.6%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

Meta Health 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

Catalist:5DX 수익, 비용 및 수입 (SGD Millions )
날짜	수익	수익	G+A 비용
30 Jun 24	1	-2	2
31 Mar 24	3	-3	3
31 Dec 23	5	-3	3
30 Jun 23	-4	-6	-1
31 Mar 23	4	-7	2
31 Dec 22	11	-7	5
30 Sep 22	38	-5	13
30 Jun 22	42	-2	14
31 Mar 22	42	0	13
31 Dec 21	43	1	13
30 Sep 21	41	4	12
30 Jun 21	39	0	11
31 Mar 21	35	-1	11
31 Dec 20	32	-2	11
30 Sep 20	34	-2	11
30 Jun 20	36	-2	12
31 Mar 20	41	-1	13
31 Dec 19	45	0	13
30 Sep 19	46	-1	15
30 Jun 19	46	-3	16
31 Mar 19	47	-4	17
31 Dec 18	47	-5	18
30 Sep 18	49	-6	18
30 Jun 18	51	-6	19
31 Mar 18	53	-7	20
31 Dec 17	56	-9	20
30 Sep 17	58	-8	20
30 Jun 17	61	-6	21
31 Mar 17	57	-4	19
31 Dec 16	53	-2	18
30 Jun 16	47	1	14
31 Mar 16	50	1	14
31 Dec 15	52	1	14
30 Sep 15	60	0	18
30 Jun 15	61	-1	18
31 Mar 15	65	-2	20
31 Dec 14	69	-3	21
30 Sep 14	70	-3	21
30 Jun 14	71	-2	21
31 Mar 14	70	-1	20
31 Dec 13	69	0	20
30 Sep 13	68	1	18

양질의 수익: 5DX 은(는) 현재 수익성이 없습니다.

이익 마진 증가: 5DX 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: 5DX 은(는) 수익성이 없으며 지난 5년 동안 연간 20% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 5DX 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: 5DX 은(는) 수익성이 없어 지난 해 수익 성장을 Machinery 업계( -11% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: 5DX 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

Meta Health 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

First half 2024 earnings released: EPS: S$0 (vs S$0.004 loss in 1H 2023)

Full year 2023 earnings released: S$0.004 loss per share (vs S$0.016 loss in FY 2022)

First half 2023 earnings released: S$0.004 loss per share (vs S$0.005 loss in 1H 2022)

Full year 2022 earnings released: S$0.013 loss per share (vs S$0.018 profit in FY 2021)

Meta Health Limited to Report Fiscal Year 2022 Results on Mar 01, 2023

First half 2022 earnings released

Recent updates

First half 2024 earnings released: EPS: S$0 (vs S$0.004 loss in 1H 2023)

New major risk - Share price stability

Meta Health Limited Announces the Appointment of Cheah You Kong as the Acting Head of Finance and as an Executive Officer, Effective May 1, 2024

Meta Health Limited, Annual General Meeting, Apr 29, 2024

High number of new directors

Meta Health Limited Announces Resignation of Tan Sze Leng as Chief Financial Officer, Effective from 17 May 2024

New major risk - Negative shareholders equity

Full year 2023 earnings released: S$0.004 loss per share (vs S$0.016 loss in FY 2022)

New minor risk - Financial data availability

Meta Health Limited Announces the Cessation of Mr. Chua Kheng Choon as Senior Vice President of Engineering

High number of new and inexperienced directors

New major risk - Shareholder dilution

High number of new and inexperienced directors

Meta Health Limited Appoints Lim Qing Ru as Independent Non-Executive Director, Member of the Audit Committee, the Nominating Committee and the Remuneration Committee, Effective from 1 November 2023

New major risk - Share price stability

New major risk - Revenue and earnings growth

First half 2023 earnings released: S$0.004 loss per share (vs S$0.005 loss in 1H 2022)

New major risk - Share price stability

Full year 2022 earnings released: S$0.013 loss per share (vs S$0.018 profit in FY 2021)

Meta Health Limited to Report Fiscal Year 2022 Results on Mar 01, 2023

Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effect from 12 December 2022

Executive Chairman & Group CEO recently bought S$59k worth of stock

Meta Health Limited Appoints Tan Sze Leng as Chief Financial Officer, Effective from 21 September 2022

Executive Chairman & Group CEO recently bought S$59k worth of stock

First half 2022 earnings released

Meta Health Limited Provides Financial Guidance for the First Half Year Ended June 30, 2022

High number of new and inexperienced directors

Meta Health Limited Announces Appointment of Law Ren Kai Kenneth as Independent Non-Executive Director, Chairman of the Audit Committee, and A Member of the Nominating Committee and the Remuneration Committee

Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effective 12 December 2022

Meta Health Limited Announces Resignation Leow Siew Yon, Cynthia as Independent Non-Executive Director, Chairman of the Nominating Committee, and a Member of the Audit Committee and the Remuneration Committee

Meta Health Limited Announces Management Changes

Full year 2021 earnings released: EPS: S$0.018 (vs S$0.005 loss in FY 2020)

Meta Health Limited, Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Now 23% undervalued after recent price drop

Metal Precision Services Pte Ltd. completed the acquisition of 85.07% stake in Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian.

Metal Component Engineering Limited (Catalist:5DX) agreed to acquire Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian for SGD 11.1 million.

Metal Component Engineering Considers Potential Acquisition

Independent Non-Executive Director has left the company

Full year 2020 earnings released

Metal Component Engineering Limited Announces Board Changes, Effective January 1, 2021

Metal Component Engineering Limited Provides Group Earnings Guidance for the Half Year Ended 30 June 2020

Metal Component Engineering Limited to Report First Half, 2020 Results on Aug 14, 2020

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기